RMD vs SYK
RMD: ResMed develops cloud-connected software platforms and digital devices for out-of-hospital care, spanning sleep apnea management, COPD treatment, and residential care operations. SYK: A diversified global MedTech leader providing surgical instruments, robotics, and advanced clinical technologies to enhance patient recovery and healthcare outcomes.
Side-by-side fundamentals
| Metric | RMD | SYK | Edge |
|---|---|---|---|
| Price as of 2026-07-27 close | $203.08 | $336.74 | |
| Market cap as of 2026-08-01 | $29.5B | $129.1B | |
| P/E as of 2026-08-01 | 20.08 | 37.33 | RMD lower |
| PEG as of 2026-08-01 | 1.22 | 3.68 | RMD lower |
| Net margin as of 2026-08-01 | +27.4% | +13.2% | RMD higher |
| Gross margin as of 2026-08-01 | +61.6% | +64.2% | SYK higher |
| Operating margin as of 2026-08-01 | +34.2% | +19.7% | RMD higher |
| ROE as of 2026-08-01 | +24.4% | +15.1% | RMD higher |
| ROA as of 2026-08-01 | +18.0% | +7.1% | RMD higher |
| Debt / equity as of 2026-08-01 | 0.10 | 0.64 | RMD lower |
| Revenue growth (YoY) as of 2026-08-01 | +10.3% | +8.8% | RMD higher |
| Revenue CAGR (3y) SEC XBRL | +12.9% | +10.8% | RMD higher |
| Dividend yield as of 2026-08-01 | +1.2% | +1.0% | RMD higher |
| Dividend streak (yrs) SEC XBRL | 5 | 5 | Tie |
| Beta as of 2026-08-01 | 0.75 | 0.77 | |
| 1-year return as of 2026-07-27 close | -26.2% | -16.6% | SYK higher |
Fundamentals: market data, as of 2026-08-01. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-27.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.